{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:38:24Z","timestamp":1778769504808,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02926-3","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:02:41Z","timestamp":1725663761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Torsemide Crystalline Salts with a Significant Spring-Parachute Effect"],"prefix":"10.1208","volume":"25","author":[{"given":"Xuezhen","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3983-4704","authenticated-orcid":false,"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"issue":"2","key":"2926_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2165\/00002018-199614020-00005","volume":"14","author":"DC Brater","year":"1996","unstructured":"Brater DC. Benefits and risks of torasemide in congestive heart failure and essential hypertension. Drug Saf. 1996;14(2):104\u201320. https:\/\/doi.org\/10.2165\/00002018-199614020-00005.","journal-title":"Drug Saf"},{"issue":"1","key":"2926_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/01.HYP.34.1.138","volume":"34","author":"A Fortuno","year":"1999","unstructured":"Fortuno A, Muniz P, Ravassa S, et al. Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension. 1999;34(1):138\u201343. https:\/\/doi.org\/10.1161\/01.HYP.34.1.138.","journal-title":"Hypertension"},{"issue":"5","key":"2926_CR3","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/jvim.15864","volume":"34","author":"B Besche","year":"2020","unstructured":"Besche B, Blondel T, Guillot E, et al. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study. J Vet Intern Med. 2020;34(5):1746\u201358. https:\/\/doi.org\/10.1111\/jvim.15864.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2926_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jep.13261","volume":"26","author":"NA Sherif","year":"2020","unstructured":"Sherif NA, Morra ME, Thanh LV, et al. Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials. J Eval Clin Prac. 2020;26(3):842\u201351. https:\/\/doi.org\/10.1111\/jep.13261.","journal-title":"J Eval Clin Prac"},{"issue":"3","key":"2926_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.addr.2003.10.011","volume":"56","author":"AS Raw","year":"2004","unstructured":"Raw AS, Furness MS, Gill DS, et al. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Adv Drug Deliv Rev. 2004;56(3):397\u2013414. https:\/\/doi.org\/10.1016\/j.addr.2003.10.011.","journal-title":"Adv Drug Deliv Rev"},{"key":"2926_CR6","unstructured":"Dash TR, Mukherjee B. Development and characterisation of liposomal delivery system containing diuretic drug torsemide (Doctoral dissertation). 2010."},{"key":"2926_CR7","doi-asserted-by":"publisher","first-page":"135624","DOI":"10.1016\/j.molstruc.2023.135624","volume":"1286","author":"AS Priya","year":"2023","unstructured":"Priya AS, Sivakamavalli J, Vaseeharan B, et al. Interaction of torsemide with native cyclodextrin through inclusion complexation: In-vitro drug release, antibacterial and antibiofilm activities[J]. J Mol Struct. 2023;1286:135624. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135624.","journal-title":"J Mol Struct"},{"key":"2926_CR8","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1208\/s12249-016-0697-6","volume":"18","author":"AA El-Shenawy","year":"2017","unstructured":"El-Shenawy AA, Ahmed MM, Mansour HF, et al. Torsemide fast dissolving tablets: Development, optimization using Box-Bhenken design and response surface methodology, in vitro characterization, and pharmacokinetic assessment[J]. AAPS PharmSciTech. 2017;18:2168\u201379. https:\/\/doi.org\/10.1208\/s12249-016-0697-6.","journal-title":"AAPS PharmSciTech"},{"issue":"23","key":"2926_CR9","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1039\/D2CE00383J","volume":"24","author":"M Garg","year":"2022","unstructured":"Garg M, Singh MK, Koli SM, et al. Crystalline salts of a diuretic drug torasemide with improved solubility and dissolution properties. CrystEngComm. 2022;24(23):4235\u201350. https:\/\/doi.org\/10.1039\/D2CE00383J.","journal-title":"CrystEngComm"},{"key":"2926_CR10","unstructured":"Lv Y, Du GH. Crystalline drugs. Pharmaceutical Co-Crystallization Technology, Beijing: People's Medical Publishing House, 2019, p: 155\u2013185."},{"issue":"15","key":"2926_CR11","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1039\/D0CE00178C","volume":"22","author":"W Kuang","year":"2020","unstructured":"Kuang W, Ji S, Wei Y, et al. A new 1:1 cocrystal of lamotrigine and 1, 2, 3, 6-hydrophthalimide: discovery, characterization, and construction of ternary phase diagrams. CrystEngComm. 2020;22(15):2681\u20138. https:\/\/doi.org\/10.1039\/D0CE00178C.","journal-title":"CrystEngComm"},{"issue":"3","key":"2926_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1021\/acs.molpharmaceut.0c01045","volume":"18","author":"R Devarapalli","year":"2021","unstructured":"Devarapalli R, Indukuri A, Bollineni M, et al. Investigation of poor solubility of a salt-cocrystal hydrate: A case study of the common-ion effect in Betrixaban, an anticoagulant drug. Mol Pharmaceut. 2021;18(3):1138\u201349. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01045.","journal-title":"Mol Pharmaceut"},{"key":"2926_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejpb.2021.05.030","volume":"166","author":"YW Li","year":"2021","unstructured":"Li YW, Zhang HM, Cui BJ, et al. \u201cFelodipine-indomethacin\u201d co-amorphous supersaturating drug delivery systems: \u201cSpring-parachute\u201d process, stability, in vivo bioavailability, and underlying molecular mechanisms. Eur J Pharm Biopharm. 2021;166:111\u201325. https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.030.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"2926_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1021\/acs.jced.6b00855","volume":"62","author":"D Li","year":"2017","unstructured":"Li D, Li S, Meng L, et al. Solid-liquid phase equilibria of ternary systems LiCl-LiBr-H2O and CaCl2-CaBr 2\u2013H2O at 288.15 K. J Chem Eng Data. 2017;62(2):833\u20138. https:\/\/doi.org\/10.1021\/acs.jced.6b00855.","journal-title":"J Chem Eng Data."},{"issue":"5","key":"2926_CR15","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1021\/acs.cgd.5b00268","volume":"15","author":"S Mittapalli","year":"2015","unstructured":"Mittapalli S, Mannava MKC, Khandavilli UBR, et al. Soluble salts and cocrystals of clotrimazole[J]. Cryst Growth Des. 2015;15(5):2493\u2013504. https:\/\/doi.org\/10.1021\/acs.cgd.5b00268.","journal-title":"Cryst Growth Des"},{"issue":"26","key":"2926_CR16","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1021\/jm701032y","volume":"50","author":"GS Paulekuhn","year":"2007","unstructured":"Paulekuhn GS, Dressman JB, Saal C. Trends in active pharmaceutical ingredient salt selection based on analysis of the orange book database. J Med Chem. 2007;50(26):6665\u201372. https:\/\/doi.org\/10.1021\/jm701032y.","journal-title":"J Med Chem"},{"issue":"1","key":"2926_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1039\/C1CS15171A","volume":"41","author":"SL James","year":"2012","unstructured":"James SL, Adams CJ, Bolm C, et al. Mechanochemistry: opportunities for new and cleaner synthesis. Chem Soc Rev. 2012;41(1):413\u201347. https:\/\/doi.org\/10.1039\/C1CS15171A.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"2926_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/pharmaceutics10010018","volume":"10","author":"A Karagianni","year":"2018","unstructured":"Karagianni A, Malamatari M, Kachrimanis K. Pharmaceutical cocrystals: New solid phase modification approaches for the formulation of APIs. Pharmaceutics. 2018;10(1):18. https:\/\/doi.org\/10.3390\/pharmaceutics10010018.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2926_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0736-4679(83)90009-4","volume":"1","author":"CE Becker","year":"1983","unstructured":"Becker CE. Methanol poisoning. J Emerg Med. 1983;1(1):51\u20138. https:\/\/doi.org\/10.1016\/0736-4679(83)90009-4.","journal-title":"J Emerg Med"},{"issue":"11","key":"2926_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/0024-3205(91)90504-5","volume":"48","author":"TR Tephly","year":"1991","unstructured":"Tephly TR. The toxicity of methanol. Life Sci. 1991;48(11):1031\u201341. https:\/\/doi.org\/10.1016\/0024-3205(91)90504-5.","journal-title":"Life Sci"},{"issue":"1","key":"2926_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/cg020063o","volume":"3","author":"JL Atwood","year":"2003","unstructured":"Atwood JL, Barbour LJ. Molecular graphics: from science to art. Cryst Growth Des. 2003;3(1):3\u20138. https:\/\/doi.org\/10.1021\/cg020063o.","journal-title":"Cryst Growth Des"},{"issue":"2","key":"2926_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1107\/S002188980403225X","volume":"38","author":"MC Burla","year":"2005","unstructured":"Burla MC, Caliandro R, Camalli M, et al. SIR2004: an improved tool for crystal structure determination and refinement. J Appl Crystallogr. 2005;38(2):381\u20138. https:\/\/doi.org\/10.1107\/S002188980403225X.","journal-title":"J Appl Crystallogr"},{"issue":"2","key":"2926_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1107\/S0021889808042726","volume":"42","author":"OV Dolomanov","year":"2009","unstructured":"Dolomanov OV, Bourhis LJ, Gildea RJ, et al. OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr. 2009;42(2):339\u201341. https:\/\/doi.org\/10.1107\/S0021889808042726.","journal-title":"J Appl Crystallogr"},{"issue":"1","key":"2926_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053273314026370","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick GM. SHELXT-Integrated space-group and crystal-structure determination. Acta Crystallogr A. 2015;71(1):3\u20138. https:\/\/doi.org\/10.1107\/S2053273314026370.","journal-title":"Acta Crystallogr A"},{"issue":"12","key":"2926_CR25","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1021\/acs.molpharmaceut.9b00851","volume":"16","author":"C Hu","year":"2019","unstructured":"Hu C, Liu Z, Liu C, et al. Enhanced oral bioavailability and anti-echinococcosis efficacy of albendazole achieved by optimizing the \u201cspring\u201d and \u201cparachute\u201d[J]. Mol Pharmaceut. 2019;16(12):4978\u201386. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00851.","journal-title":"Mol Pharmaceut"},{"issue":"2","key":"2926_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acs.molpharmaceut.5b00837","volume":"13","author":"C Liu","year":"2016","unstructured":"Liu C, Chen Z, Chen Y, et al. Improving oral bioavailability of sorafenib by optimizing the \u201cspring\u201d and \u201cparachute\u201d based on molecular interaction mechanisms[J]. Mol Pharmaceut. 2016;13(2):599\u2013608. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00837.","journal-title":"Mol Pharmaceut"},{"issue":"3","key":"2926_CR27","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1021\/cg901412d","volume":"10","author":"T Lee","year":"2010","unstructured":"Lee T, Wang PY. Screening, manufacturing, photoluminescence, and molecular recognition of co-crystals: cytosine with dicarboxylic acids[J]. Cryst Growth Des. 2010;10(3):1419\u201334. https:\/\/doi.org\/10.1021\/cg901412d.","journal-title":"Cryst Growth Des"},{"issue":"19","key":"2926_CR28","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1039\/C2CE25724F","volume":"14","author":"JM Chen","year":"2012","unstructured":"Chen JM, Wang ZZ, Wu CB, et al. Crystal engineering approach to improve the solubility of mebendazole[J]. CrystEngComm. 2012;14(19):6221\u20139. https:\/\/doi.org\/10.1039\/C2CE25724F.","journal-title":"CrystEngComm"},{"issue":"9","key":"2926_CR29","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1021\/acs.cgd.9b00770","volume":"19","author":"ON Kavanagh","year":"2019","unstructured":"Kavanagh ON, Walker G, Lusi M. Graph-set analysis helps to understand charge transfer in a novel ionic cocrystal when the \u0394pKa rule fails[J]. Cryst Growth Des. 2019;19(9):5308\u201313. https:\/\/doi.org\/10.1021\/acs.cgd.9b00770.","journal-title":"Cryst Growth Des"},{"issue":"81","key":"2926_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1039\/B406676F","volume":"6","author":"M Czugler","year":"2004","unstructured":"Czugler M, B\u00e1thori N. Weak C-H\u00b7\u00b7\u00b7O interactions and their r\u00f4le in simple amine crystal structures. CrystEngComm. 2004;6(81):495\u2013503. https:\/\/doi.org\/10.1039\/B406676F.","journal-title":"CrystEngComm"},{"issue":"1","key":"2926_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1107\/S2052520615018582","volume":"72","author":"G Zhang","year":"2016","unstructured":"Zhang G, Zhang L, Yang D, et al. Salt screening and characterization of ciprofloxacin[J]. Acta Crystallogr B. 2016;72(1):20\u20138. https:\/\/doi.org\/10.1107\/S2052520615018582.","journal-title":"Acta Crystallogr B"},{"issue":"4","key":"2926_CR32","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1021\/acs.molpharmaceut.7b00003","volume":"14","author":"HL Lee","year":"2017","unstructured":"Lee HL, Vasoya JM, Cirqueira ML, et al. Continuous preparation of 1: 1 haloperidol-maleic acid salt by a novel solvent-free method using a twin screw melt extruder[J]. Mol Pharmaceut. 2017;14(4):1278\u201391. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00003.","journal-title":"Mol Pharmaceut"},{"issue":"4","key":"2926_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/cryst11040379","volume":"11","author":"MI Tamboli","year":"2021","unstructured":"Tamboli MI, Okamoto Y, Utsumi Y, et al. Crystal structures of antiarrhythmic drug disopyramide and its salt with phthalic acid[J]. Crystals. 2021;11(4):379. https:\/\/doi.org\/10.3390\/cryst11040379.","journal-title":"Crystals"},{"issue":"14","key":"2926_CR34","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1039\/c2ce25386k","volume":"14","author":"CC da Silva","year":"2012","unstructured":"da Silva CC, Coelho RR, de Lima CM, et al. Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids[J]. CrystEngComm. 2012;14(14):4562\u20136. https:\/\/doi.org\/10.1039\/c2ce25386k.","journal-title":"CrystEngComm"},{"issue":"1\u20133","key":"2926_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molstruc.2011.08.010","volume":"1004","author":"S Jin","year":"2011","unstructured":"Jin S, Guo J, Liu L, et al. Five organic salts assembled from carboxylic acids and bis-imidazole derivatives through collective noncovalent interactions[J]. J Mol Struct. 2011;1004(1\u20133):227\u201336. https:\/\/doi.org\/10.1016\/j.molstruc.2011.08.010.","journal-title":"J Mol Struct"},{"issue":"4","key":"2926_CR36","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cg100099w","volume":"10","author":"HG Brittain","year":"2010","unstructured":"Brittain HG. Vibrational spectroscopic studies of cocrystals and salts. 3. Cocrystal products formed by benzenecarboxylic acids and their sodium salts[J]. Cryst Growth Des. 2010;10(4):1990\u20132003. https:\/\/doi.org\/10.1021\/cg100099w.","journal-title":"Cryst Growth Des"},{"key":"2926_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.saa.2016.05.042","volume":"167","author":"CC da Silva","year":"2016","unstructured":"da Silva CC, Guimar\u00e3es FF, Ribeiro L, et al. Salt or cocrystal of salt? Probing the nature of multicomponent crystal forms with infrared spectroscopy[J]. Spectrochim Acta A. 2016;167:89\u201395. https:\/\/doi.org\/10.1016\/j.saa.2016.05.042.","journal-title":"Spectrochim Acta A"},{"issue":"15","key":"2926_CR38","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1021\/jp003802p","volume":"105","author":"EMS Maco\u02c6as","year":"2001","unstructured":"Maco\u02c6as EMS, Fausto R, Lundell J, et al. A matrix isolation spectroscopic and quantum chemical study of fumaric and maleic acid[J]. J Phys Chem A. 2001;105(15):3922\u201333. https:\/\/doi.org\/10.1021\/jp003802p.","journal-title":"J Phys Chem A"},{"issue":"1","key":"2926_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1107\/S2052520615021022","volume":"72","author":"D Rychkov","year":"2016","unstructured":"Rychkov D, Arkhipov S, Boldyreva E. Structure-forming units of amino acid maleates. Case study of l-valinium hydrogen maleate[J]. Acta Crystallogr B. 2016;72(1):160\u20133. https:\/\/doi.org\/10.1107\/S2052520615021022.","journal-title":"Acta Crystallogr B"},{"issue":"4","key":"2926_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/10837450.2021.1888978","volume":"26","author":"A Hamideh","year":"2021","unstructured":"Hamideh A, Rahman Z, Dharani S, et al. Preparation and characterization of dicarboxylic acids salt of aripiprazole with enhanced physicochemical properties[J]. Pharm Dev Technol. 2021;26(4):455\u201363. https:\/\/doi.org\/10.1080\/10837450.2021.1888978.","journal-title":"Pharm Dev Technol"},{"issue":"7","key":"2926_CR41","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1021\/cg200492w","volume":"11","author":"NJ Babu","year":"2011","unstructured":"Babu NJ, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 2011;11(7):2662\u201379. https:\/\/doi.org\/10.1021\/cg200492w.","journal-title":"Cryst Growth Des"},{"issue":"54","key":"2926_CR42","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1039\/C6CC02943D","volume":"52","author":"G Bolla","year":"2016","unstructured":"Bolla G, Nangia A. Pharmaceutical cocrystals: walking the talk. Chem Commun. 2016;52(54):8342\u201360. https:\/\/doi.org\/10.1039\/C6CC02943D.","journal-title":"Chem Commun"},{"issue":"10","key":"2926_CR43","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/jps.20906","volume":"96","author":"HR Guzm\u00e1n","year":"2007","unstructured":"Guzm\u00e1n HR, Tawa M, Zhang Z, et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations[J]. J Pharm Sci. 2007;96(10):2686\u2013702. https:\/\/doi.org\/10.1002\/jps.20906.","journal-title":"J Pharm Sci"},{"issue":"37","key":"2926_CR44","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1039\/D1CC07187D","volume":"58","author":"MKC Mannava","year":"2022","unstructured":"Mannava MKC, Bommaka MK, Dandela R, et al. Fluorobenzoic acid coformers to improve the solubility and permeability of the BCS class IV drug naftopidil[J]. Chem Commun. 2022;58(37):5582\u20135. https:\/\/doi.org\/10.1039\/D1CC07187D.","journal-title":"Chem Commun"},{"issue":"2","key":"2926_CR45","doi-asserted-by":"publisher","first-page":"2200151","DOI":"10.1002\/crat.202200151","volume":"58","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Shi J, Liu L, et al. Improving solubility and avoiding hygroscopicity of tetrahydropalmatine by forming a pharmaceutical salt cocrystal via CAHBs[J]. Cryst Res Technol. 2023;58(2):2200151. https:\/\/doi.org\/10.1002\/crat.202200151.","journal-title":"Cryst Res Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02926-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02926-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02926-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:07:49Z","timestamp":1729696069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02926-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["2926"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02926-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"210"}}